Suppr超能文献

相似文献

2
Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients.
Ann Clin Transl Neurol. 2023 Sep;10(9):1544-1555. doi: 10.1002/acn3.51844. Epub 2023 Jul 13.
3
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.
Brain. 2008 Jul;131(Pt 7):1759-75. doi: 10.1093/brain/awn098. Epub 2008 Jun 5.
4
Clinical and radiological characteristics and outcomes of patients with recurrent or relapsing tumefactive demyelination.
Mult Scler Relat Disord. 2024 Feb;82:105408. doi: 10.1016/j.msard.2023.105408. Epub 2024 Jan 5.
5
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Eur J Neurol. 2021 Apr;28(4):1299-1307. doi: 10.1111/ene.14672. Epub 2021 Jan 12.
6
Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Mult Scler. 2012 Oct;18(10):1448-53. doi: 10.1177/1352458512438237. Epub 2012 Mar 14.
7
Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments.
Mult Scler J Exp Transl Clin. 2019 Jun 18;5(2):2055217319855755. doi: 10.1177/2055217319855755. eCollection 2019 Apr-Jun.
8
Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Acta Radiol. 2011 Dec 1;52(10):1159-68. doi: 10.1258/ar.2011.110007. Epub 2011 Oct 24.

引用本文的文献

1
Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination.
Mult Scler. 2025 Sep 8:13524585251371984. doi: 10.1177/13524585251371984.
3
Tumefactive Demyelinating Lesions: An Illustrative Pediatric Case With an Atypical Presentation and Literature Review.
Cureus. 2024 May 28;16(5):e61207. doi: 10.7759/cureus.61207. eCollection 2024 May.
4
Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis.
J Neurol. 2024 Aug;271(8):5275-5289. doi: 10.1007/s00415-024-12349-6. Epub 2024 Jun 11.
5
Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
Sci Rep. 2024 Jan 16;14(1):1426. doi: 10.1038/s41598-024-52048-w.
6
Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis.
J Neurol. 2024 Apr;271(4):1663-1667. doi: 10.1007/s00415-023-12164-5. Epub 2023 Dec 28.
7
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study.
Sci Rep. 2023 Dec 1;13(1):21235. doi: 10.1038/s41598-023-46313-7.
8
Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients.
Ann Clin Transl Neurol. 2023 Sep;10(9):1544-1555. doi: 10.1002/acn3.51844. Epub 2023 Jul 13.
9
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Neurology. 2023 Mar 28;100(13):e1418-e1432. doi: 10.1212/WNL.0000000000206820. Epub 2023 Jan 23.

本文引用的文献

1
Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes.
Neurology. 2021 Nov 9;97(19):e1906-e1913. doi: 10.1212/WNL.0000000000012782. Epub 2021 Sep 9.
2
Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis.
Neurology. 2021 Jul 27;97(4):e414-e422. doi: 10.1212/WNL.0000000000012230. Epub 2021 May 19.
3
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.
JAMA Neurol. 2021 Jun 1;78(6):741-746. doi: 10.1001/jamaneurol.2021.0912.
5
Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments.
Mult Scler J Exp Transl Clin. 2019 Jun 18;5(2):2055217319855755. doi: 10.1177/2055217319855755. eCollection 2019 Apr-Jun.
6
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.
J Neurol. 2018 Oct;265(10):2251-2259. doi: 10.1007/s00415-018-8984-7. Epub 2018 Jul 27.
7
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
J Neuroinflammation. 2018 May 3;15(1):134. doi: 10.1186/s12974-018-1144-2.
8
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
9
Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.
J Neurol Sci. 2017 Oct 15;381:32-38. doi: 10.1016/j.jns.2017.08.005. Epub 2017 Aug 12.
10
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.
Neuroradiol J. 2016 Oct;29(5):384-9. doi: 10.1177/1971400916665385. Epub 2016 Aug 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验